The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,481.00
Bid: 1,477.50
Ask: 1,478.50
Change: 9.50 (0.65%)
Spread: 1.00 (0.068%)
Open: 1,476.50
High: 1,492.00
Low: 1,460.00
Prev. Close: 1,471.50
PSN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

16 Apr 2014 07:00

RNS Number : 9142E
Persimmon PLC
16 April 2014
 



INTERIM MANAGEMENT STATEMENT

 

WEDNESDAY 16 APRIL 2014

 

 

Persimmon plc ("the Company") will hold its Annual General Meeting ("AGM") at 12.00 noon today at York Racecourse when the Chairman will make the following statement regarding current trading, financial performance and the outlook for the current financial year. This statement covers the period from 1 January 2014 to date and supplements the update given with the 2013 Final Results on 25 February 2014.

 

The new financial year has started well with visitor levels to our sites up 10% over the prior year during the initial fifteen weeks of trading. Cancellation rates over this period of 14% continue to run at historically low levels (2013: 15%).

 

Our weekly private sales rate per site for the first fifteen weeks of 2014 was 25% ahead of the prior year. Together with the strong sales position brought forward into the new year, this improved rate of sale results in current total forward sales of £1.87 billion for 2014, which includes legal completions taken so far this year. Total forward sales revenue is 35% higher than in 2013 (£1.38 billion). We have c.7,200 new homes sold forward into the private sale market for 2014 which is 38% ahead of the same point last year, with an average selling price of c.£200,400 which is c.3% higher.

 

We currently have c.395 active sites across the UK and have successfully opened 75 of the 90 new outlets targeted for the first half of 2014 to refresh this network. Our build activity continues to support the improved rates of sale and we remain confident of delivering further growth in the number of new homes legally completed for 2014.

 

The Government sponsored Help to Buy shared equity scheme in England reached its first anniversary on 1 April 2014 and we have now sold c.5,000 new homes to customers using mortgages associated with this scheme, of which 2,203 legally completed in 2013. In addition, we have sold a further c.600 new homes in Scotland and Wales to customers using similar mortgage products in these regional markets.

 

The recently announced extension of Help to Buy from March 2016 to March 2020 provides welcome support to potential new home purchasers for this additional four year period. As a consequence, and with the support of the mortgage lending industry, housebuilders have the opportunity to continue to increase the industry's development commitments in support of increasing the number of new homes delivered to the market over the medium term.

 

Our strategy remains focussed on exercising capital discipline through the cycle whilst growing the business as market conditions allow. Our commitment to return c.£1.9 billion of surplus capital to shareholders over the period to 2021 is a key feature of this capital discipline. In the Final Results statement on 25 February 2014 the Directors announced a further acceleration of this programme of capital return. Subject to shareholder approval at the AGM, the second payment of the Capital Return Plan of c.£213 million, or 70p per share, will be paid to shareholders on 4 July 2014. This 70p per share payment is a part acceleration of the 115p final payment originally planned for 2021. The record date is 6.00 p.m. on 4 June 2014 and the shares trade ex-entitlement from 8.00 a.m. on 5 June 2014.

 

In line with the approach adopted with the first payment under the Capital Return Plan in 2013, the Directors will offer shareholders the opportunity, where possible, to choose to receive the cash either as a return of capital or as dividend income by way of a B / C share scheme. Full details of the B / C share proposal have been sent to shareholders with the notice of the Company's AGM. The closing date for elections to be made by shareholders is 11.00 a.m. on 20 June 2014.

 

The Directors are pleased to announce that the Company has recently concluded an amendment of its £300 million Revolving Credit Facility with the Company's five relationship banks. The new facility has been extended to a maturity date of 31 March 2019.

 

We will provide a further report on progress in our Trading Update on Wednesday 2 July 2014.

 

For further information please contact:-

 

Jeff Fairburn, Group Chief Executive

Simon Rigby

Mike Killoran, Group Finance Director

Kevin Smith

Persimmon plc

Lindsay Noton

Tel: +44 (0) 20 7638 9571 on the day

Citigate Dewe Rogerson

Tel: +44 (0) 1904 642199 thereafter

Tel: +44 (0) 20 7638 9571

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUVANRSKASAAR
Date   Source Headline
2nd Apr 20206:14 pmRNSFurther Update on Covid-19 – Board Remuneration
1st Apr 20209:51 amRNSTotal Voting Rights
25th Mar 20207:00 amRNSCovid-19, Capital Return Plan and AGM Updates
17th Mar 20203:42 pmRNSAnnual Financial Report
16th Mar 20207:00 amRNSAppointment of Joint Corporate Broker
5th Mar 20204:47 pmRNSDirector/PDMR Shareholding
2nd Mar 202011:05 amRNSTotal Voting Rights
27th Feb 20207:00 amRNSCEO Succession
27th Feb 20207:00 amRNSFinal Results
17th Feb 20207:00 amRNSBoard Change
3rd Feb 202012:00 pmRNSTotal Voting Rights
15th Jan 20207:02 amRNSBoard Change
15th Jan 20207:00 amRNSTrading Update
2nd Jan 202011:01 amRNSTotal Voting Rights
2nd Dec 201912:45 pmRNSBlock listing Interim Review
18th Nov 20193:48 pmRNSAdditional Listing
7th Nov 20197:00 amRNSThird Quarter Trading Statement
1st Nov 201912:18 pmRNSTotal Voting Rights
21st Oct 20193:09 pmRNSBoard Changes
17th Oct 20192:39 pmRNSDirector/PDMR Shareholding
15th Oct 201911:19 amRNSAdditional Listing
1st Oct 20192:37 pmRNSTotal Voting Rights
20th Aug 20198:41 amRNSHalf-year results - Amendment
20th Aug 20197:00 amRNSHalf-year Results
1st Aug 20195:40 pmRNSTotal Voting Rights
4th Jul 20197:00 amRNSTrading Update
11th Jun 20197:18 amRNSDirector/PDMR Shareholding
3rd Jun 20191:53 pmRNSBlock listing Interim Review
3rd Jun 20191:48 pmRNSTotal Voting Rights
23rd May 20191:07 pmRNSAdditional Listing
1st May 20194:22 pmRNSResult of AGM
1st May 201911:23 amRNSTotal Voting Rights
1st May 20197:00 amRNSTrading Update
17th Apr 20197:00 amRNSDirector Appointment
1st Apr 20191:42 pmRNSTotal Voting Rights
21st Mar 20197:00 amRNSCustomer Care Improvement Plan
18th Mar 20192:30 pmRNSAnnual Financial Report
12th Mar 20193:19 pmRNSAdditional Listing
4th Mar 20191:36 pmRNSDirector/PDMR Shareholding
1st Mar 20194:34 pmRNSTotal Voting Rights
26th Feb 20197:00 amRNSCEO Appointment
26th Feb 20197:00 amRNSFinal Results
1st Feb 20194:36 pmRNSTotal Voting Rights
15th Jan 20197:00 amRNSTrading Update
11th Jan 20195:55 pmRNSHolding(s) in Company
2nd Jan 201912:55 pmRNSTotal Voting Rights
11th Dec 201810:18 amRNSDirector/PDMR Shareholding
7th Dec 201812:04 pmRNSDirector/PDMR Shareholding
6th Dec 20184:53 pmRNSDirector/PDMR Shareholding
4th Dec 20183:25 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.